Thomas Jahn

Thomas leads the Cardiopulmonary Biology team for Dewpoint Therapeutics. Most recently, he was a Group Leader in the Neuroscience Discovery organization at AbbVie in Germany.

During his career in academia and pharmaceutical research, Thomas has founded a research laboratory at the German Cancer Research Center in Heidelberg focusing on generic concepts of protein misfolding disorders and has held a range of leadership roles for pre-clinical drug discovery projects. He has key expertise in establishing innovative disease models and translational strategies, and enjoys developing new therapeutic modalities for challenging drug discovery targets.

Thomas is a biochemist by training, holds a Ph.D. in Structural Biology from the University of Leeds and has performed his postdoctoral work at the University of Cambridge.